Clinical Case Based Review of Ultrasound
This course includes cases covering all aspects of diagnostic ultrasound. The course describes management decisions affecting a variety of commonly encountered clinical scenarios. In-Training Members will receive a discounted price of $175 after login.
Target Audience:
The target audience for this activity includes in-training radiologists preparing for exams and active practice, as well as practicing radiologists with an interest in honing their diagnostic skills in ultrasound.
Goals and Objectives:
After completing this course, the learner should be able to:
- Develop differential diagnoses for ultrasound findings.
- Recognize the imaging and clinical features that allow for refinement of differential diagnosis, allowing for a more specific diagnosis.
- Recognize some commonly encountered imaging artifacts in ultrasound and describe why they occur and the techniques to avoid them.
- Outline management decisions affecting a variety of commonly encountered clinical scenarios.
Disclosure of Commercial Interest:
ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners disclosures:
Module 1
Module 2
Module 3
Module 1
- C. Santillan is the recipient of an honorarium from Robarts Clinical Trials.
- K. Cummings has nothing to disclose.
- D. Naeger has nothing to disclose.
- C. Deurdulian has nothing to disclose.
- A. Kamaya has nothing to disclose.
- G. Joshi has nothing to disclose.
- A. Kennedy is the recipient of book royalties from Amirsys, Inc. and Elsevier.
- S. Bhatt has nothing to disclose.
Module 2
- C. Santillan is the recipient of an honorarium from Robarts Clinical Trials.
- A. Paladin has nothing to disclose
- C. Deurdulian has nothing to disclose.
- A. Kennedy receives royalties from Amirsys and Elsevier.
- G. Joshi has nothing to disclose.
- A. Kamaya receives royalties from Amirsys and Elsevier.
Module 3
- C. Santillan is the recipient of an honorarium from Robarts Clinical Trials.
- A. Paladin has nothing to disclose
- G. Joshi has nothing to disclose.
- A. Kamaya receives book royalties from Elsevier.
- A. Kennedy receives book royalties from Amirsys/Elsevier.
- C. Deurdulian received a speaker's honorarium from Neurologica/Samsung.
Member Price:
$345.00
NonMember Price:
$595.00
Accreditation Statement
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement
The ARRS designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
Date of issuance: September 27, 2019
Date of expiration: September 26, 2025
Estimated time to complete the activity: 5 hour(s)
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement
The ARRS designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ARRS designates this enduring activity for a maximum of 5 AMA PRA Category 1 Credit(s)™ and 5 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME.) Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of issuance: September 27, 2019
Date of expiration: September 26, 2025
Estimated time to complete the activity: 5 hour(s)